T-cell therapy has shown remarkable clinical efficacy in haematological malignancies, currently representing a well ...

The data demonstrates promising efficacy and a favorable safety profile for IBI343 in patients with advanced gastric cancer whose tumors express CLDN18.2. Gastric cancer is one of the most common ...